Marco Edilson Freire de Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Edilson Freire de Lima has a total of 248 co-authors. Here are the top co-authors by number of shared publications:
- Afonso Santine Magalhaes Mesquita Velez
Universidade Federal Rural do Rio de Janeiro, Instituto de Química
13 shared publications - Leonardo Freire-De-Lima
Programa de Pós-Graduação em Ciências Biológicas (Biofísica), Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil
13 shared publications - Otávio Augusto Chaves
Department of Chemistry, Coimbra Chemistry Centre—Institute of Molecular Science (CQC-IMS), University of Coimbra, Rua Larga s/n, 3004-535 Coimbra, Portugal
12 shared publications - Debora Decote-Ricardo
Departamento de Veterinária, Universidade Federal Rural do Rio de Janeiro, Rio de Janeiro, Brazil
11 shared publications - Celio Geraldo Freire-De-Lima
Programa de Pós-Graduação em Ciências Biológicas (Biofísica), Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil
8 shared publications - Jose Osvaldo Previato
Programa de Pós-Graduação em Ciências Biológicas (Biofísica), Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil
8 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Omega
Antitrypanosomal Activity of Natural Product-Inspired Chalcones and Dihydrochalcones: Computational Insights into a Potential Mechanism of Action
Chalcones (CHAs) and dihydrochalcones (DHCs) are flavonoid-related compounds with diverse biological activities. In this study, four chalcones (CHA-1–4) and their corresponding dihydrochalcones (DHC-1–4) were tested against intracellular forms of Trypanosoma cruzi, the cause of Chagas disease. CHA-3 was commercially available, while the other chalcones were synthesized using Claisen–Schmidt condensation, and the dihydrochalcones were obtained via selective hydrogenation. All compounds exhibited moderate antitrypanosomal activity, with IC50 values from 12.90 to 37.57 μM, and DHC-4 was the most potent derivative. A molecular modeling study indicated glyceraldehyde-3-phosphate dehydrogenase as a candidate T. cruzi target, presenting a strong correlation between predicted binding energies of the compounds and their experimental activities (R = 0.99). Additionally, in silico ADME-Tox analyses indicated favorable physicochemical and pharmacokinetic properties, providing a basis for developing more potent and selective antitrypanosomal agents based on chalcone and dihydrochalcone frameworks.
- 10 November 2026
- Published by American Chemical Society (ACS) in ACS Omega
Open AccessAntitrypanosomal Activity of Natural Product-Inspired Chalcones and Dihydrochalcones: Computational Insights into a Potential Mechanism of Action
Chalcones (CHAs) and dihydrochalcones (DHCs) are flavonoid-related compounds with diverse biological activities. In this study, four chalcones (CHA-1–4) and their corresponding dihydrochalcones (DHC-1–4) were tested against intracellular forms of Trypanosoma cruzi, the cause of Chagas disease. CHA-3 was commercially available, while the other chalcones were synthesized using Claisen–Schmidt condensation, and the dihydrochalcones were obtained via selective hydrogenation. All compounds exhibited moderate antitrypanosomal activity, with IC50 values from 12.90 to 37.57 μM, and DHC-4 was the most potent derivative. A molecular modeling study indicated glyceraldehyde-3-phosphate dehydrogenase as a candidate T. cruzi target, presenting a strong correlation between predicted binding energies of the compounds and their experimental activities (R = 0.99). Additionally, in silico ADME-Tox analyses indicated favorable physicochemical and pharmacokinetic properties, providing a basis for developing more potent and selective antitrypanosomal agents based on chalcone and dihydrochalcone frameworks.
- Open Access
- 21 July 2026
- Published by Wiley in ChemFoodChem
- Vol. 2 (3) , e00045
Free Phenolic Hydroxyl Groups Govern the Anticancer Activity of α‐Mangostin: A Structure–Activity Relationship Insight
The α‐mangostin ( MGT ) is a natural xanthone obtained from the pericarp of mangosteen fruit ( Garcinia mangostana Linn.), possessing a widely reported biological activity, including anticancer, anti‐inflammatory, antibacterial, and antiviral properties. However, the impact of its free phenolic hydroxyl groups on achieving biological activity has not yet been evaluated. In this context, the present work isolated and characterized MGT from mangosteen and obtained the semisynthetic acetylated mangostin ( AcMGT ) to evaluate its drug‐likeness, interaction profile with the serine/threonine‐protein kinase AKT (isoform AKT1), and anticancer profile using in silico and in vitro approaches. The semisynthetic compound AcMGT is stable for up to 48 h under mimetic biological conditions; however, the acetylation decreased the anticancer profile of MGT in murine colon cancer, murine triple negative breast cancer, and human osteosarcoma cancer (CT26, 4T1, and U2OS, respectively), for example, from 7.55 ± 0.10 to 29.90 ± 1.20 µM in 4T1, which might be expected due to the decrease in the interactive profile with AKT1. The fluorescence microscopy indicated that acetylation reduced MGT 's capacity to induce vacuolization in 4T1 cells, and the drug‐likeness prediction for AcMGT decreased markedly compared with the natural product, highlighting the importance of free phenolic hydroxyl groups in MGT for achieving the expected anticancer profile.
- 21 July 2026
- Published by Wiley in ChemFoodChem
- Vol. 2 (3) , e00045
Open AccessFree Phenolic Hydroxyl Groups Govern the Anticancer Activity of α‐Mangostin: A Structure–Activity Relationship Insight
The α‐mangostin ( MGT ) is a natural xanthone obtained from the pericarp of mangosteen fruit ( Garcinia mangostana Linn.), possessing a widely reported biological activity, including anticancer, anti‐inflammatory, antibacterial, and antiviral properties. However, the impact of its free phenolic hydroxyl groups on achieving biological activity has not yet been evaluated. In this context, the present work isolated and characterized MGT from mangosteen and obtained the semisynthetic acetylated mangostin ( AcMGT ) to evaluate its drug‐likeness, interaction profile with the serine/threonine‐protein kinase AKT (isoform AKT1), and anticancer profile using in silico and in vitro approaches. The semisynthetic compound AcMGT is stable for up to 48 h under mimetic biological conditions; however, the acetylation decreased the anticancer profile of MGT in murine colon cancer, murine triple negative breast cancer, and human osteosarcoma cancer (CT26, 4T1, and U2OS, respectively), for example, from 7.55 ± 0.10 to 29.90 ± 1.20 µM in 4T1, which might be expected due to the decrease in the interactive profile with AKT1. The fluorescence microscopy indicated that acetylation reduced MGT 's capacity to induce vacuolization in 4T1 cells, and the drug‐likeness prediction for AcMGT decreased markedly compared with the natural product, highlighting the importance of free phenolic hydroxyl groups in MGT for achieving the expected anticancer profile.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1812023
Structure-enabled enhancement of potency in a metronidazole–benznidazole hybrid: design, synthesis, and evaluation of antitrypanosomal activity of a benzylamide-linked 5-nitroimidazole
Benznidazole ( 1 ) remains the primary antiparasitic drug used clinically for Chagas disease, underscoring the need to discover novel treatments targeting Trypanosoma cruzi ( T. cruzi ) infection. In this sense, the present work reports the in silico design of a novel hybrid ( 3 ) containing the 5-nitroimidazole core from the commercial antiparasitic drug metronidazole ( 2 ) and the N -benzylacetamide moiety from 1 . These structural motifs were designed to target T. cruzi nitroreductase type I (TcNTR) for activation and to boost intracellular drug levels (lipophilicity). The in silico predictions suggested that the presence of the N -benzylacetamide moiety might enhance the anti-T . cruzi activity of 2 and improve the drug-likeness. To validate the predictions, hybrid 3 was synthesized with a yield of 53% and structurally characterized (melting point, 1 H and 13 C NMR, and HRMS). The in vitro assays of hybrid 3 against T. cruzi amastigotes (Tulahuen strain C2C4 LacZ ) supported the in silico predictions, showing a lower IC 50 for 3 (67.73 ± 8.98 µM) than for 2 (>100 µM). Despite hybrid 3 having an activity 45-fold lower than that of 1 , the results provide insights for future hybrid optimization.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1812023
Open AccessStructure-enabled enhancement of potency in a metronidazole–benznidazole hybrid: design, synthesis, and evaluation of antitrypanosomal activity of a benzylamide-linked 5-nitroimidazole
Benznidazole ( 1 ) remains the primary antiparasitic drug used clinically for Chagas disease, underscoring the need to discover novel treatments targeting Trypanosoma cruzi ( T. cruzi ) infection. In this sense, the present work reports the in silico design of a novel hybrid ( 3 ) containing the 5-nitroimidazole core from the commercial antiparasitic drug metronidazole ( 2 ) and the N -benzylacetamide moiety from 1 . These structural motifs were designed to target T. cruzi nitroreductase type I (TcNTR) for activation and to boost intracellular drug levels (lipophilicity). The in silico predictions suggested that the presence of the N -benzylacetamide moiety might enhance the anti-T . cruzi activity of 2 and improve the drug-likeness. To validate the predictions, hybrid 3 was synthesized with a yield of 53% and structurally characterized (melting point, 1 H and 13 C NMR, and HRMS). The in vitro assays of hybrid 3 against T. cruzi amastigotes (Tulahuen strain C2C4 LacZ ) supported the in silico predictions, showing a lower IC 50 for 3 (67.73 ± 8.98 µM) than for 2 (>100 µM). Despite hybrid 3 having an activity 45-fold lower than that of 1 , the results provide insights for future hybrid optimization.
- Open Access
Novel 1,4-Naphthoquinone-Zidovudine Hybrid: Design, Synthesis, and In Vitro Evaluation of Its Anti-Trypanosomatid and Cytotoxic Activities
This work reports the synthesis and characterization of a new molecular hybrid 4, created by combining 1,4-naphthoquinone with the drug zidovudine (AZT) through an azide-alkyne cycloaddition reaction catalyzed by Cu1+. In vitro studies assessed the anti-trypanosomatid activity of hybrid 4, along with its precursors and synthetic intermediates (1, 2, and 3), against Trypanosoma cruzi (T. cruzi Tulahuen C2C4 LacZ), Trypanosoma brucei (T. b. brucei 427), and Leishmania infantum, as well as cytotoxicity in RAW 264.7 macrophages and LLC-MK2 cells. The biological results confirm the molecular design, showing that the new hybrid is effective against both epimastigotes and amastigotes of T. cruzi (IC50 = 22.26 ± 5.78 μM and 143.10 ± 5.79 μM, respectively), with approximately 4.5-fold better capacity than AZT to inhibit the epimastigote form. Additionally, the hybrid was also active against bloodstream T. b. brucei (IC50 = 54.47 ± 6.70 μM), with approximately 2.2-fold better capacity than AZT to inhibit this parasite. It also shows low toxicity in RAW 264.7 macrophages (CC50 > 200 μM) and LLC-MK2 cells (CC50 > 200 μM). For example, hybrid 4 exhibited approximately a 6.6-fold higher SI than 1,4-naphthoquinone 1 against T. cruzi amastigotes. In this context, the work contributes to the broader knowledge base guiding the design of hybrid molecules for antiparasitic chemotherapy. It provides a rational foundation for preparing subsequent, more potent analogues.
Open AccessNovel 1,4-Naphthoquinone-Zidovudine Hybrid: Design, Synthesis, and In Vitro Evaluation of Its Anti-Trypanosomatid and Cytotoxic Activities
This work reports the synthesis and characterization of a new molecular hybrid 4, created by combining 1,4-naphthoquinone with the drug zidovudine (AZT) through an azide-alkyne cycloaddition reaction catalyzed by Cu1+. In vitro studies assessed the anti-trypanosomatid activity of hybrid 4, along with its precursors and synthetic intermediates (1, 2, and 3), against Trypanosoma cruzi (T. cruzi Tulahuen C2C4 LacZ), Trypanosoma brucei (T. b. brucei 427), and Leishmania infantum, as well as cytotoxicity in RAW 264.7 macrophages and LLC-MK2 cells. The biological results confirm the molecular design, showing that the new hybrid is effective against both epimastigotes and amastigotes of T. cruzi (IC50 = 22.26 ± 5.78 μM and 143.10 ± 5.79 μM, respectively), with approximately 4.5-fold better capacity than AZT to inhibit the epimastigote form. Additionally, the hybrid was also active against bloodstream T. b. brucei (IC50 = 54.47 ± 6.70 μM), with approximately 2.2-fold better capacity than AZT to inhibit this parasite. It also shows low toxicity in RAW 264.7 macrophages (CC50 > 200 μM) and LLC-MK2 cells (CC50 > 200 μM). For example, hybrid 4 exhibited approximately a 6.6-fold higher SI than 1,4-naphthoquinone 1 against T. cruzi amastigotes. In this context, the work contributes to the broader knowledge base guiding the design of hybrid molecules for antiparasitic chemotherapy. It provides a rational foundation for preparing subsequent, more potent analogues.
- Open Access
- 26 December 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (1) , 1546-1556
Contribution to the Chemotherapy of Human Trypanosomiasis: Design, Synthesis, and Biological Evaluation of Dimeric 2-Nitroimidazoles against Trypanosoma cruzi Amastigotes and Bloodstream Trypanosoma brucei
Effective and safe treatments for neglected tropical diseases caused by parasites, such as Chagas disease and sleeping sickness, remain lacking, posing a significant challenge for researchers worldwide. The rational design of dimeric compounds inspired solely by the pharmacophoric core of benznidazole (2-nitroimidazole) has proven to be a promising strategy for antiparasitic development. Thus, in the present work, it was increased the linker between the active units (2-nitroimidazole) to improve the interaction with TcNTR, facilitating the bioactivation of the longest dimers. Biological assays confirmed this, demonstrating that all compounds were active against replicative intracellular amastigotes of Trypanosoma cruzi (Tulahuen C2C4-LacZ). Notably, longer-chain dimers exhibited remarkable potency (IC50 < 1.0 μM). These compounds also showed significant activity against T. b. brucei and demonstrated very low cytotoxicity in mammalian cells, highlighting their selectivity, especially among the longer-chain dimers. These findings support the development of dimeric 2-nitroimidazole derivatives as selective agents against trypanosomes.
- 26 December 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (1) , 1546-1556
Open AccessContribution to the Chemotherapy of Human Trypanosomiasis: Design, Synthesis, and Biological Evaluation of Dimeric 2-Nitroimidazoles against Trypanosoma cruzi Amastigotes and Bloodstream Trypanosoma brucei
Effective and safe treatments for neglected tropical diseases caused by parasites, such as Chagas disease and sleeping sickness, remain lacking, posing a significant challenge for researchers worldwide. The rational design of dimeric compounds inspired solely by the pharmacophoric core of benznidazole (2-nitroimidazole) has proven to be a promising strategy for antiparasitic development. Thus, in the present work, it was increased the linker between the active units (2-nitroimidazole) to improve the interaction with TcNTR, facilitating the bioactivation of the longest dimers. Biological assays confirmed this, demonstrating that all compounds were active against replicative intracellular amastigotes of Trypanosoma cruzi (Tulahuen C2C4-LacZ). Notably, longer-chain dimers exhibited remarkable potency (IC50 < 1.0 μM). These compounds also showed significant activity against T. b. brucei and demonstrated very low cytotoxicity in mammalian cells, highlighting their selectivity, especially among the longer-chain dimers. These findings support the development of dimeric 2-nitroimidazole derivatives as selective agents against trypanosomes.
- Open Access
- 28 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (10) , 2272
The Capsular Polysaccharides GXM and GXMGal from Cryptococcus neoformans Modulate Macrophages Infected with Leishmania major
Leishmania spp. are obligatory intracellular parasites that primarily infect macrophages. The macrophage immune response plays a pivotal role in determining the control or progression of infection. “M1-like” macrophages mediate parasite clearance through the production of nitric oxide, pro-inflammatory cytokines, and reactive oxygen species, whereas “M2-like” macrophages contribute to infection progression by exerting anti-inflammatory effects. The capsular polysaccharides Glucuronoxylomannan (GXM) and glucuronoxylomannogalactan (GXMGal) from Cryptococcus neoformans are capable of immunomodulating the macrophage response. GXM exhibits immunoregulatory activity, whereas GXMGal induces a pro-inflammatory response. Although the activity of these polysaccharides has been studied in cryptococcosis, their immunomodulatory potential in other infectious models remains largely unexplored. Here, we investigated the effects of GXM and GXMGal on Leishmania major infection in murine peritoneal macrophages. Murine peritoneal macrophages were infected with L. major and, 24 h post-infection, treated with 50 μg of either GXM or GXMGal. Our data revealed that GXM treatment enhanced L. major infection, while GXMGal treatment had no significant effect on the parasitic load in infected macrophages.
- 28 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (10) , 2272
Open AccessThe Capsular Polysaccharides GXM and GXMGal from Cryptococcus neoformans Modulate Macrophages Infected with Leishmania major
Leishmania spp. are obligatory intracellular parasites that primarily infect macrophages. The macrophage immune response plays a pivotal role in determining the control or progression of infection. “M1-like” macrophages mediate parasite clearance through the production of nitric oxide, pro-inflammatory cytokines, and reactive oxygen species, whereas “M2-like” macrophages contribute to infection progression by exerting anti-inflammatory effects. The capsular polysaccharides Glucuronoxylomannan (GXM) and glucuronoxylomannogalactan (GXMGal) from Cryptococcus neoformans are capable of immunomodulating the macrophage response. GXM exhibits immunoregulatory activity, whereas GXMGal induces a pro-inflammatory response. Although the activity of these polysaccharides has been studied in cryptococcosis, their immunomodulatory potential in other infectious models remains largely unexplored. Here, we investigated the effects of GXM and GXMGal on Leishmania major infection in murine peritoneal macrophages. Murine peritoneal macrophages were infected with L. major and, 24 h post-infection, treated with 50 μg of either GXM or GXMGal. Our data revealed that GXM treatment enhanced L. major infection, while GXMGal treatment had no significant effect on the parasitic load in infected macrophages.
- 21 August 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 323 (Pt 1) , 147020
Studies on the toxic effects of three regioisomeric methoxylated xanthones against Trypanosoma cruzi amastigotes and their binding with human serum albumin
- 21 August 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 323 (Pt 1) , 147020
Studies on the toxic effects of three regioisomeric methoxylated xanthones against Trypanosoma cruzi amastigotes and their binding with human serum albumin
- Open Access
Studies on a New 1,3,4-Oxadiazole Bixin Dimer for Potential Application in Dye-Sensitized Solar Cells
Dye-sensitized solar cells (DSSCs) have emerged as a promising technology for converting sunlight into electricity at a low cost; however, it is still necessary to find a photostable, low-cost, and efficient photosensitizer. In this sense, the natural product bixin (Dye 1) has previously been reported as a potential photosensitizer. Thus, the present work reports the full synthesis of diester and diacid hybrids (Dyes 2 and 3, respectively, with corresponding yields of 93% and 52%) using the natural product bixin as a starting material and 1,3,4-oxadiazole ring as a connected point. The hydrolysis step of Dye 2 aims to obtain Dye 3 with a structural capacity to anchor the titanium dioxide (TiO2) nanofilms via the carboxylic acid group. Both compounds (Dyes 1 and 3) can be adsorbed via pseudo-first order on the surface of TiO2 nanofilms, reaching saturation after 10 and 6 min of exposure in an organic solution (1 × 10−5 M), respectively, with adsorption kinetics of the semisynthetic compound almost twofold higher than the natural product. Contrary to expectations, Dye 3 had spectral behavior similar to Dye 1, but with better frontier molecular orbital (FMO) parameters, indicating that Dye 3 will probably behave very similarly or have slightly better photovoltaic performance than Dye 1 in future DSSC measurements.
Open AccessStudies on a New 1,3,4-Oxadiazole Bixin Dimer for Potential Application in Dye-Sensitized Solar Cells
Dye-sensitized solar cells (DSSCs) have emerged as a promising technology for converting sunlight into electricity at a low cost; however, it is still necessary to find a photostable, low-cost, and efficient photosensitizer. In this sense, the natural product bixin (Dye 1) has previously been reported as a potential photosensitizer. Thus, the present work reports the full synthesis of diester and diacid hybrids (Dyes 2 and 3, respectively, with corresponding yields of 93% and 52%) using the natural product bixin as a starting material and 1,3,4-oxadiazole ring as a connected point. The hydrolysis step of Dye 2 aims to obtain Dye 3 with a structural capacity to anchor the titanium dioxide (TiO2) nanofilms via the carboxylic acid group. Both compounds (Dyes 1 and 3) can be adsorbed via pseudo-first order on the surface of TiO2 nanofilms, reaching saturation after 10 and 6 min of exposure in an organic solution (1 × 10−5 M), respectively, with adsorption kinetics of the semisynthetic compound almost twofold higher than the natural product. Contrary to expectations, Dye 3 had spectral behavior similar to Dye 1, but with better frontier molecular orbital (FMO) parameters, indicating that Dye 3 will probably behave very similarly or have slightly better photovoltaic performance than Dye 1 in future DSSC measurements.
- Open Access
- 27 May 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (22) , 23397-23408
C-methylated Flavanones with Antitrypanosomal Activity Isolated of Geopropolis from Melipona mondury
Geopropolis is a natural antibiotic produced by stingless bees, supplemented with earth and clay. Bee products are a promising source of natural bioactive compounds with potential for the development of new drugs for neglected tropical diseases, such as Chagas disease. This study analyzed extracts of Melipona mondury geopropolis from the Bosque da Barra da Tijuca (RJ, Brazil) and evaluated their activity against Trypanosoma cruzi. The extracts were obtained using commercial grain alcohol 96° GL and fractionated with hexane and dichloromethane. The antichagasic activity was determined, with IC50 values ranging from 4.54 to 53.02 μg/mL. Phytochemical investigation of the dichloromethane fraction resulted in the isolation of two C-methylated flavanones, (2S)-strobopinin and (2S)-cryptostrobin, which were identified for the first time in Brazilian geopropolis. These compounds showed IC50 values of 21.21 μM and 21.55 μM, respectively, with distinct cytotoxities: 33.80 μM for strobopinin and 99.79 μM for cryptostrobin. Molecular modeling studies were conducted to propose a mechanism of action on a candidate enzyme target, glyceraldehyde-3-phosphate dehydrogenase, and possible reasons for the selectivity differences caused by C-methylation. The results highlight M. mondury geopropolis as a promising natural source of antiparasitic agents, supporting its potential for drug development.
- 27 May 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (22) , 23397-23408
Open AccessC-methylated Flavanones with Antitrypanosomal Activity Isolated of Geopropolis from Melipona mondury
Geopropolis is a natural antibiotic produced by stingless bees, supplemented with earth and clay. Bee products are a promising source of natural bioactive compounds with potential for the development of new drugs for neglected tropical diseases, such as Chagas disease. This study analyzed extracts of Melipona mondury geopropolis from the Bosque da Barra da Tijuca (RJ, Brazil) and evaluated their activity against Trypanosoma cruzi. The extracts were obtained using commercial grain alcohol 96° GL and fractionated with hexane and dichloromethane. The antichagasic activity was determined, with IC50 values ranging from 4.54 to 53.02 μg/mL. Phytochemical investigation of the dichloromethane fraction resulted in the isolation of two C-methylated flavanones, (2S)-strobopinin and (2S)-cryptostrobin, which were identified for the first time in Brazilian geopropolis. These compounds showed IC50 values of 21.21 μM and 21.55 μM, respectively, with distinct cytotoxities: 33.80 μM for strobopinin and 99.79 μM for cryptostrobin. Molecular modeling studies were conducted to propose a mechanism of action on a candidate enzyme target, glyceraldehyde-3-phosphate dehydrogenase, and possible reasons for the selectivity differences caused by C-methylation. The results highlight M. mondury geopropolis as a promising natural source of antiparasitic agents, supporting its potential for drug development.
- Open Access
- 24 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 456
Design and Synthesis of Bis-Chalcones as Curcumin Simplified Analogs and Assessment of Their Antiproliferative Activities Against Human Lung Cancer Cells and Trypanosoma cruzi Amastigotes
Background: Anticancer therapies represent the primary treatment option for a significant number of cancer patients globally; however, many of these treatments are associated with severe side effects as they target molecular structures present in both cancerous and healthy cells. In a similar context, the treatment of Chagas disease, a neglected tropical illness, is hindered by the high toxicity of the currently available drugs. Researchers are increasingly focusing on the development of safer and more selective alternatives, with natural compounds being studied as potential starting points for the creation of more effective drug candidates with a favorable therapeutic index. Objectives: The aim of this study was to design simplified curcumin-derived structures that preserved or enhanced their therapeutic activity against human lung cancer cell lines and T. cruzi, while also improving bioavailability and minimizing toxicity. Methods: In this study, curcumin and two natural curcuminoids inspired the synthesis of a chalcone and a set of bis-chalcones, compound classes known for their enhanced stability compared with their natural parent derivatives. The synthetic strategy used was the acid-catalyzed aldol condensation reaction. The stability profiles, IC50 values against A549 and H460 tumor cell lines, and trypanocidal activity against T. cruzi amastigotes of these derivatives were assessed. Results: The synthesized derivatives exhibited improved stability compared with the parent compounds, along with lower IC50 values in both A549 and H460 tumor cell lines. Additionally, one of the new analogs showed promising trypanocidal activity against T. cruzi amastigotes. Conclusions: This study provides a potential pathway toward the development of more effective and less toxic treatments for both cancer and Chagas disease. The simplified curcumin derivatives represent a promising foundation for designing new therapeutic agents with improved bioavailability and efficacy.
- 24 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 456
Open AccessDesign and Synthesis of Bis-Chalcones as Curcumin Simplified Analogs and Assessment of Their Antiproliferative Activities Against Human Lung Cancer Cells and Trypanosoma cruzi Amastigotes
Background: Anticancer therapies represent the primary treatment option for a significant number of cancer patients globally; however, many of these treatments are associated with severe side effects as they target molecular structures present in both cancerous and healthy cells. In a similar context, the treatment of Chagas disease, a neglected tropical illness, is hindered by the high toxicity of the currently available drugs. Researchers are increasingly focusing on the development of safer and more selective alternatives, with natural compounds being studied as potential starting points for the creation of more effective drug candidates with a favorable therapeutic index. Objectives: The aim of this study was to design simplified curcumin-derived structures that preserved or enhanced their therapeutic activity against human lung cancer cell lines and T. cruzi, while also improving bioavailability and minimizing toxicity. Methods: In this study, curcumin and two natural curcuminoids inspired the synthesis of a chalcone and a set of bis-chalcones, compound classes known for their enhanced stability compared with their natural parent derivatives. The synthetic strategy used was the acid-catalyzed aldol condensation reaction. The stability profiles, IC50 values against A549 and H460 tumor cell lines, and trypanocidal activity against T. cruzi amastigotes of these derivatives were assessed. Results: The synthesized derivatives exhibited improved stability compared with the parent compounds, along with lower IC50 values in both A549 and H460 tumor cell lines. Additionally, one of the new analogs showed promising trypanocidal activity against T. cruzi amastigotes. Conclusions: This study provides a potential pathway toward the development of more effective and less toxic treatments for both cancer and Chagas disease. The simplified curcumin derivatives represent a promising foundation for designing new therapeutic agents with improved bioavailability and efficacy.